Technology innovation group Battelle launched a new suite of services aimed at improving cybersecurity in the medtech sector.
Researchers touted a major breakthrough this week when a paraplegic patients successfully moved his own hand using only signals from his own mind.
The technology is comprised of a microchip implanted in the brain and a "sleeve" laden with electrodes that stimulates the muscles in the arm in precise coordination with signals from the brain. Unlike other technologies that rely on robotics or computers to move paralyzed limbs, the so-called "NeuroBridge" system translates brain signals into muscle stimulation.
Although the FDA has only recently begun addressing medical device cybersecurity in an official capacity, device makers would do well to take notice that the agency has ramped up its oversight quickly over the last year.
Medical device executives and Ted Talk-ers love comparing the medtech industry to consumer electronics or aeronautics when making grand points about the market, but at Battelle cross-industry correlations speak to the core of the company’s engineering philosophy.
MASSDEVICE ON CALL — The Mass. Life Sciences Center, a quasi-public agency that oversees state dollars allocated toward increasing the life sciences industry’s footprint in the Bay State, doled out another $3.8 million in “accelerator” loans.
The program is designed to provide a boost to early-stage life science companies that the center’s scientific advisory board deems to have a high potential for commercialization, rapid growth and the ability to raise substantial capital.